About the journal
European Journal of Cancer is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,800 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1879-0852 · 0959-8049
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 3,800 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/european-journal-of-cancer
Index listings
- MEDLINE · 1990-01-01
- PUBMED · 1999-12-01
- Indexing
- MEDLINE · PUBMED
- APC
- 3,800 USD
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
41994
Last recorded publication year
2026
h-index
297
i10-index
11375
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 44%
- ORCID iDs in current deposits
- 27%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- European journal of cancer. A
- Source type
- journal
- NLM unique ID (PubMed)
- 9005373
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
Show all subjects (50)
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Cancer survivorship and care
- Cancer survivorship and care
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Breast Lesions and Carcinomas
- Breast Lesions and Carcinomas
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
- Cancer therapeutics and mechanisms
- Cancer therapeutics and mechanisms
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ